• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

晚期糖基化终产物受体(RAGE)在生理和糖尿病条件下对骨代谢的影响。

The effects of the receptor for advanced glycation end products (RAGE) on bone metabolism under physiological and diabetic conditions.

机构信息

Division of Nephrology and Kidney Center, Kobe University School of Medicine, Kobe, Japan.

出版信息

Endocrine. 2010 Dec;38(3):369-76. doi: 10.1007/s12020-010-9390-9. Epub 2010 Oct 23.

DOI:10.1007/s12020-010-9390-9
PMID:20972729
Abstract

It has been reported that AGEs and the receptor for AGEs (RAGEs) have been linked to the pathogenesis of diabetic microangiopathy. However, the relationship between RAGE and alteration in bone metabolism is unclear. Therefore, in order to determine the role of RAGE in bone metabolism, we investigated the effects of RAGE deletion on bone metabolism under physiological and diabetic conditions using RAGE knockout mice (RAGE-KO). Eight-week-old male RAGE-KO and wild-type littermates (WT) were intraperitoneally injected with either streptozotocin or vehicle. Mice were classified into four groups: (1) nondiabetic WT; (2) nondiabetic RAGE-KO; (3) diabetic WT; and (4) diabetic RAGE-KO. After 12 weeks of streptozotocin or vehicle treatment, the physical properties of femora and the static and dynamic parameters of bone histomorphometry of tibiae were assessed. The deletion of RAGE affected neither body weights nor hemoglobin A1c levels. RAGE deletion resulted in increased bone mineral density due to decreased osteoclast function under physiological conditions that is no accumulation of AGEs. In contrast, lacking RAGE did not affect the alteration in bone metabolism under diabetic conditions, suggesting that AGEs-RAGE interaction may not be involved in the pathogenesis of diabetic osteopenia, although RAGE plays a crucial role in bone metabolism.

摘要

已有报道称,糖基化终产物(AGEs)及其受体(RAGEs)与糖尿病微血管病变的发病机制有关。然而,RAGE 与骨代谢改变之间的关系尚不清楚。因此,为了确定 RAGE 在骨代谢中的作用,我们使用 RAGE 敲除小鼠(RAGE-KO)研究了 RAGE 缺失在生理和糖尿病条件下对骨代谢的影响。将 8 周龄雄性 RAGE-KO 和野生型同窝仔鼠(WT)经腹腔注射链脲佐菌素或载体。将小鼠分为四组:(1)非糖尿病 WT;(2)非糖尿病 RAGE-KO;(3)糖尿病 WT;和(4)糖尿病 RAGE-KO。链脲佐菌素或载体处理 12 周后,评估股骨的物理特性以及胫骨的静态和动态骨组织形态计量学参数。在生理条件下,由于破骨细胞功能下降导致 AGEs 无积累,RAGE 的缺失导致骨矿物质密度增加。相比之下,在糖尿病条件下,RAGE 的缺失并未影响骨代谢的改变,表明 AGEs-RAGE 相互作用可能与糖尿病性骨质疏松症的发病机制无关,尽管 RAGE 在骨代谢中起关键作用。

相似文献

1
The effects of the receptor for advanced glycation end products (RAGE) on bone metabolism under physiological and diabetic conditions.晚期糖基化终产物受体(RAGE)在生理和糖尿病条件下对骨代谢的影响。
Endocrine. 2010 Dec;38(3):369-76. doi: 10.1007/s12020-010-9390-9. Epub 2010 Oct 23.
2
Thioredoxin-1 overexpression in transgenic mice attenuates streptozotocin-induced diabetic osteopenia: a novel role of oxidative stress and therapeutic implications.转基因小鼠中硫氧还蛋白-1过表达减轻链脲佐菌素诱导的糖尿病性骨质减少:氧化应激的新作用及治疗意义
Bone. 2009 May;44(5):936-41. doi: 10.1016/j.bone.2008.12.011. Epub 2008 Dec 24.
3
Receptor for advanced glycation end products mediates inflammation and enhanced expression of tissue factor in vasculature of diabetic apolipoprotein E-null mice.晚期糖基化终末产物受体介导糖尿病载脂蛋白E基因敲除小鼠血管炎症及组织因子表达增强。
Arterioscler Thromb Vasc Biol. 2001 Jun;21(6):905-10. doi: 10.1161/01.atv.21.6.905.
4
Deletion Enhances Ischemic Muscle Inflammation, Angiogenesis, and Blood Flow Recovery in Diabetic Mice.缺失增强糖尿病小鼠缺血肌肉的炎症反应、血管生成及血流恢复。
Arterioscler Thromb Vasc Biol. 2017 Aug;37(8):1536-1547. doi: 10.1161/ATVBAHA.117.309714. Epub 2017 Jun 22.
5
Deletion of bone-marrow-derived receptor for AGEs (RAGE) improves renal function in an experimental mouse model of diabetes.在糖尿病实验小鼠模型中,剔除骨髓源性晚期糖基化终末产物受体(RAGE)可改善肾功能。
Diabetologia. 2014 Sep;57(9):1977-85. doi: 10.1007/s00125-014-3291-z. Epub 2014 Jun 24.
6
Regulation of osteoclast function and bone mass by RAGE.RAGE对破骨细胞功能和骨量的调节作用。
J Exp Med. 2006 Apr 17;203(4):1067-80. doi: 10.1084/jem.20051947. Epub 2006 Apr 10.
7
Advanced glycation endproduct (AGE) accumulation and AGE receptor (RAGE) up-regulation contribute to the onset of diabetic cardiomyopathy.晚期糖基化终产物(AGE)的积累和 AGE 受体(RAGE)的上调导致糖尿病心肌病的发生。
J Cell Mol Med. 2009 Aug;13(8B):1751-1764. doi: 10.1111/j.1582-4934.2008.00547.x.
8
The role of the receptor for advanced glycation end-products in a murine model of silicosis.晚期糖基化终产物受体在矽肺小鼠模型中的作用。
PLoS One. 2010 Mar 19;5(3):e9604. doi: 10.1371/journal.pone.0009604.
9
Up-regulated expression of advanced glycation end-products and their receptor in the small intestine and colon of diabetic rats.糖尿病大鼠小肠和结肠中晚期糖基化终产物及其受体的表达上调。
Dig Dis Sci. 2012 Jan;57(1):48-57. doi: 10.1007/s10620-011-1951-0. Epub 2011 Nov 6.
10
Protective effects of grape seed proanthocyanidin extracts on cerebral cortex of streptozotocin-induced diabetic rats through modulating AGEs/RAGE/NF-kappaB pathway.葡萄籽原花青素提取物通过调节晚期糖基化终末产物/晚期糖基化终末产物受体/核因子κB信号通路对链脲佐菌素诱导的糖尿病大鼠大脑皮层的保护作用
J Nutr Sci Vitaminol (Tokyo). 2010;56(2):87-97. doi: 10.3177/jnsv.56.87.

引用本文的文献

1
The sex-specific effects of RAGE signaling and type 2 diabetes on mouse cortical bone mechanics, structure, and material properties.晚期糖基化终末产物受体(RAGE)信号传导和2型糖尿病对小鼠皮质骨力学、结构及材料特性的性别特异性影响。
Mechanobiol Med. 2025 May 13;3(3):100132. doi: 10.1016/j.mbm.2025.100132. eCollection 2025 Sep.
2
Effect of High Glucose and Carboxymethyl-Lysine on Osteocyte Gene Expression.高糖和羧甲基赖氨酸对骨细胞基因表达的影响。
Am J Mol Biol. 2025 Apr;15(2):150-169. doi: 10.4236/ajmb.2025.152012. Epub 2025 Mar 21.
3
Complications in the spine associated with type 2 diabetes: The role of advanced glycation end-products.

本文引用的文献

1
RAGE supports parathyroid hormone-induced gains in femoral trabecular bone.RAGE 支持甲状旁腺激素引起的股骨小梁骨增加。
Am J Physiol Endocrinol Metab. 2010 Mar;298(3):E714-25. doi: 10.1152/ajpendo.00564.2009. Epub 2009 Dec 22.
2
Role of oxidative stress in diabetic bone disorder.氧化应激在糖尿病性骨病中的作用。
Bone. 2009 Jul;45 Suppl 1:S35-8. doi: 10.1016/j.bone.2009.02.004. Epub 2009 Feb 13.
3
Thioredoxin-1 overexpression in transgenic mice attenuates streptozotocin-induced diabetic osteopenia: a novel role of oxidative stress and therapeutic implications.
2型糖尿病相关的脊柱并发症:晚期糖基化终产物的作用。
Med Nov Technol Devices. 2021 Sep;11. doi: 10.1016/j.medntd.2021.100065. Epub 2021 Mar 2.
4
Crosstalk Between Senescent Bone Cells and the Bone Tissue Microenvironment Influences Bone Fragility During Chronological Age and in Diabetes.衰老骨细胞与骨组织微环境之间的串扰影响自然衰老过程及糖尿病状态下的骨脆性。
Front Physiol. 2022 Mar 21;13:812157. doi: 10.3389/fphys.2022.812157. eCollection 2022.
5
Effects of GLP-1 receptor analogue liraglutide and DPP-4 inhibitor vildagliptin on the bone metabolism in ApoE mice.胰高血糖素样肽-1受体类似物利拉鲁肽和二肽基肽酶-4抑制剂维格列汀对载脂蛋白E小鼠骨代谢的影响。
Ann Transl Med. 2019 Aug;7(16):369. doi: 10.21037/atm.2019.06.74.
6
Advanced Glycation End Products (AGEs), Receptor for AGEs, Diabetes, and Bone: Review of the Literature.晚期糖基化终末产物(AGEs)、AGEs受体、糖尿病与骨骼:文献综述
J Endocr Soc. 2019 Jul 10;3(10):1799-1818. doi: 10.1210/js.2019-00160. eCollection 2019 Oct 1.
7
Effects of knockout of the receptor for advanced glycation end-products on bone mineral density and synovitis in mice with intra-articular fractures.晚期糖基化终末产物受体基因敲除对关节内骨折小鼠骨密度和滑膜炎的影响。
J Orthop Res. 2018 Sep;36(9):2439-2449. doi: 10.1002/jor.24021. Epub 2018 May 24.
8
Bone and the innate immune system.骨与固有免疫系统。
Curr Osteoporos Rep. 2014 Mar;12(1):1-8. doi: 10.1007/s11914-014-0195-2.
9
The association between metabolic syndrome and bone mineral density: a meta-analysis.代谢综合征与骨密度的相关性:荟萃分析。
Endocrine. 2012 Dec;42(3):546-54. doi: 10.1007/s12020-012-9684-1. Epub 2012 May 1.
10
New understanding and treatments for osteoporosis.骨质疏松症的新认识与治疗方法。
Endocrine. 2012 Feb;41(1):58-69. doi: 10.1007/s12020-011-9570-2.
转基因小鼠中硫氧还蛋白-1过表达减轻链脲佐菌素诱导的糖尿病性骨质减少:氧化应激的新作用及治疗意义
Bone. 2009 May;44(5):936-41. doi: 10.1016/j.bone.2008.12.011. Epub 2008 Dec 24.
4
Nonenzymatic collagen cross-links induced by glycoxidation (pentosidine) predicts vertebral fractures.糖基化氧化诱导的非酶促胶原蛋白交联(戊糖苷)可预测椎体骨折。
J Bone Miner Metab. 2008;26(1):93-100. doi: 10.1007/s00774-007-0784-6. Epub 2008 Jan 10.
5
Bone formation in spontaneously diabetic Torii-newly established model of non-obese type 2 diabetes rats.自发性糖尿病Torii-新建立的非肥胖型2型糖尿病大鼠模型中的骨形成
Bone. 2008 Feb;42(2):372-9. doi: 10.1016/j.bone.2007.10.007. Epub 2007 Oct 22.
6
Histomorphometric analysis of diabetic osteopenia in streptozotocin-induced diabetic mice: a possible role of oxidative stress.链脲佐菌素诱导的糖尿病小鼠中糖尿病性骨质减少的组织形态计量学分析:氧化应激的可能作用
Bone. 2007 May;40(5):1408-14. doi: 10.1016/j.bone.2006.12.057. Epub 2006 Dec 24.
7
Advanced glycation end products stimulate osteoblast apoptosis via the MAP kinase and cytosolic apoptotic pathways.晚期糖基化终末产物通过丝裂原活化蛋白激酶和胞浆凋亡途径刺激成骨细胞凋亡。
Bone. 2007 Feb;40(2):345-53. doi: 10.1016/j.bone.2006.09.011. Epub 2006 Oct 24.
8
RAGE control of diabetic nephropathy in a mouse model: effects of RAGE gene disruption and administration of low-molecular weight heparin.小鼠模型中晚期糖基化终末产物受体对糖尿病肾病的调控:晚期糖基化终末产物受体基因敲除及低分子量肝素给药的影响
Diabetes. 2006 Sep;55(9):2510-22. doi: 10.2337/db06-0221.
9
Regulation of osteoclast function and bone mass by RAGE.RAGE对破骨细胞功能和骨量的调节作用。
J Exp Med. 2006 Apr 17;203(4):1067-80. doi: 10.1084/jem.20051947. Epub 2006 Apr 10.
10
Understanding RAGE, the receptor for advanced glycation end products.了解晚期糖基化终产物受体(RAGE)。
J Mol Med (Berl). 2005 Nov;83(11):876-86. doi: 10.1007/s00109-005-0688-7. Epub 2005 Aug 24.